Published in J Med Microbiol on October 07, 2010
Serratia infections: from military experiments to current practice. Clin Microbiol Rev (2011) 2.90
Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005-2010. BMC Res Notes (2012) 0.87
Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-Analyses. PLoS One (2015) 0.86
[Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia]. Enferm Infecc Microbiol Clin (2016) 0.81
Antimicrobial susceptibility and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae from intensive care units at Hamad Medical Corporation, Qatar. Antimicrob Resist Infect Control (2016) 0.78
Antimicrobial Susceptibility of Klebsiella pneumoniae and Escherichia coli with Extended-Spectrum β-lactamase associated Genes in Hospital Tengku Ampuan Afzan, Kuantan, Pahang. Malays J Med Sci (2016) 0.77
Molecular analysis and risk factors for Escherichia coli producing extended-spectrum β-lactamase bloodstream infection in hematological malignancies. PLoS One (2012) 0.77
First Report of Group CTX-M-9 Extended Spectrum Beta-Lactamases in Escherichia coli Isolates from Pediatric Patients in Mexico. PLoS One (2016) 0.75
High Diversity of CTX-M Extended-Spectrum β-Lactamases in Municipal Wastewater and Urban Wetlands. Microb Drug Resist (2015) 0.75
Association of antibiotic resistance with SHV-12 extended-spectrum β-lactamase in Enterobacter cloacae. Exp Ther Med (2015) 0.75
Molecular evaluations of extended spectrum β-lactamase producing strains of Serratia isolated from blood samples of the patients in Namazi Hospital, Shiraz, Southern Iran. Iran J Microbiol (2013) 0.75
The Prevalence of CTX-M-15 Extended-spectrum β-Lactamases Among Salmonella spp. and Shigella spp. Isolated from three Iranian Hospitals. Eur J Microbiol Immunol (Bp) (2017) 0.75
Improving the mouse model for studying the efficacy of voriconazole. J Antimicrob Chemother (2003) 1.19
Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin. J Antimicrob Chemother (2003) 1.02
Diversity of staphylococcal cassette chromosome mec structures in coagulase-negative staphylococci and relationship to drug resistance. J Med Microbiol (2009) 1.02
Development of an orogastrointestinal mucosal model of candidiasis with dissemination to visceral organs. Antimicrob Agents Chemother (2006) 0.93
Microbiological and molecular characterization of human clinical isolates of Staphylococcus cohnii, Staphylococcus hominis, and Staphylococcus sciuri. Scand J Infect Dis (2011) 0.89
Alternatives to amphotericin B for Candida rugosa infection. J Antimicrob Chemother (2004) 0.83
Evaluation of Sensititre plates for identification of clinically relevant coagulase-negative staphylococci. J Clin Microbiol (2010) 0.79
Correction: First Report of Clostridium difficile NAP1/027 in a Mexican Hospital. PLoS One (2015) 0.75
[Comparative study of a rapid testing with real time RT-PCR for diagnosis of influenza AH1N1 2009]. Salud Publica Mex (2011) 0.75